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Lack of transmission of mycobacterium abscessus among
patients with cystic fibrosis attending a single clinic
Abstract
We retrospectively analyzed 1062 respiratory specimens from 214 patients with cystic fibrosis, of whom
5 patients had 36 cultures positive for M. abscessus. Results of molecular typing demonstrated that each
of these 5 patients carried a single unique strain (genotype), which suggests that it may not be necessary
to segregate patients with CF who are colonized or infected with M. abscessus from those who are not.
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We retrospectively analyzed 1062 respiratory specimens from
214 patients with cystic fibrosis, of whom 5 patients had 36
cultures positive for M. abscessus. Results of molecular typing
demonstrated that each of these 5 patients carried a single
unique strain (genotype), which suggests that it may not be
necessary to segregate patients with CF who are colonized
or infected with M. abscessus from those who are not.
Diseases caused by nontuberculous mycobacteria are found in
patients with underlying pulmonary disease, especially those
with bronchiectasis. Cystic fibrosis (CF), the most common
life-shortening autosomal recessive disorder in populations of
European origin, leads to both obstructive and restrictive lung
disease. The course and prognosis of CF are largely determined
by recurrent infections of the respiratory tract with opportun-
istic pathogens, most commonly infection with Pseudomonas
aeruginosa. Various studies have suggested that nontuberculous
mycobacteria may worsen CF pulmonary disease [5, 12, 13].
Mycobacterium chelonae and Mycobacterium abscessus (formerly
M. chelonae subsp abscessus) are among the nontuberculous
mycobacteria that have been isolated from the respiratory tract
of patients with CF [1, 2, 8]. Most studies have not distin-
guished between these 2 species, and refer to them as “M.
chelonae group.” Histological examination provides evidence to
distinguish invasive pulmonary disease caused by M. abscessus
from mere colonization [4, 12]. A series of 154 patients with
pulmonary infection caused by rapidly growing mycobacteria
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included 9 patients with CF; the organism most frequently
isolated from these patients (including all 9 patients with CF)
was M. abscessus [6].
Extensive person-to-person spread of a strain of Pseudo-
monas aeruginosa among patients attending the same CF center
has been demonstrated [3]. Therefore, in our clinic, patients
who are colonized or infected with Pseudomonas aeruginosa are
segregated from patients for whom cultures are negative for P.
aeruginosa. For Mycobacterium tuberculosis, the principal route
of transmission is from person to person via aerosol. For non-
tuberculous mycobacteria, the route of transmission is less clear.
Therefore, we wished to determine whether person-to-person
spread of M. abscessus in patients with CF occurs, because if
cross-infection were evident, it would be beneficial to segregate
patients with CF who are colonized or infected with M. ab-
scessus from those who are not.
To address this question, we first identified all patients who
attended the CF clinic of the Medical School Hannover during
a period of 19 months (from September 1997 through March
1999). During this time period, sputum samples, tracheal as-
pirates, and specimens obtained by bronchoscopy from patients
with CF were routinely processed by the Department of Medical
Microbiology, where acid fast bacilli (AFB) smears and culture
were performed. After treating with n-acetyl–l-cysteine/sodium
hydroxide, AFB smears were performed using the fluorochrome
method, and smears with positive results were restained using
the Ziehl-Neelsen method. All specimens were incubated in the
BACTEC MGIT 960 automated culture system (Becton Dick-
inson) at 37C.
Species identification for cultures positive for acid-fast bacilli
was performed by means of PCR-mediated amplification of
selected sequences of the 16S rRNA gene and direct sequence
determination, as described elsewhere [9]. Amplified PCR
products were sequenced using an ABI automated sequencer
(Applied Biosystems) under conditions recommended by the
manufacturer. We differentiated between M. chelonae and M.
abscessus by sequencing an additional 26-bp region of the 16s
rRNA gene corresponding to Escherichia coli positions 1001 to
1027 [11]. For DNA fingerprinting, genomic DNA was digested
with DraI and then separated by pulsed field gel electrophoresis
(PFGE) as described elsewhere [14]. Cultures for bacteria and
fungi were performed on standard media. Chart reviews of all
clinic visits were done for all patients with cultures positive for
M. abscessus.
A total of 1062 specimens from 214 patients with CF were
cultured for mycobacteria, a mean of 5.0 specimens per patient.
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Figure 1. Isolation of Mycobacterium abscessus from patients with cystic fibrosis who attended a cystic fibrosis clinic during the period September
1997–March 1999. *Times at which specimens from the respiratory tract were cultured for mycobacteria. Boxed asterisks, 36 cultures positive for M.
abscessus. Arrows, 21 isolates that were subjected to analysis by pulsed-field gel electrophoresis. #Patient C had Mycobacterium avium isolated once.
Figure 2. Pulsed-field gel electrophoresis patterns for Mycobacterium
abscessus isolates from 5 patients with cystic fibrosis. The chromosomal
DNA was digested with DraI. Lane 1, isolate from patient B; lane 2,
isolate from patient A; lane 3, isolate from patient C; lane 4, isolate from
patient D; lane 5, isolate from patient E; lane 6, l DNA standard.
For 15 (7%) of 214 patients (age range, 21–35 years), cultures
were positive for various mycobacterial species: 5 patients had
cultures positive for M. abscessus, 4 for Mycobacterium intra-
cellulare, 4 for Mycobacterium avium, 2 for Mycobacterium sim-
iae, 1 for Mycobacterium interjectum, and 1 for Mycobacterium
gordonae. The recovery rate of 7% is similar to the 5% [1] and
12% [8] rates reported in other studies. Two of the 15 patients
who had cultures positive for mycobacteria had mixed infec-
tions, 1 with M. avium and M. abscessus and 1 with M. avium
and M. simiae. Chart reviews of the 5 patients with cultures
positive for M. abscessus (designated patients A–E) revealed that
patient A and patient B twice attended the outpatient clinic on
the same day (9 December 1997 and 13 March 1998). In con-
trast, patients C, D, and E had no potential contact at the clinic
with other patients who had cultures positive for M. abscessus
(see figure 1).
Possible nosocomial transmission of M. abscessus was inves-
tigated by subjecting the available isolates to molecular typing
procedures: these included 11 isolates from patient A, 6 isolates
from patient B, 2 isolates from patient C, and 1 isolate each
from patients D and E. Each of these 5 patients had isolates
of a unique genotype, unshared with the isolates of the other
patients, which indicated that person-to-person spread had not
occurred (see figure 2). On the basis of these results, we would
not recommend segregation of patients who are colonized or
infected with M. abscessus. All isolates from patient A and all
isolates form patient B were identical, which suggests that
chronic colonization or infection due to a single strain (ge-
notype) was present in these patients for 13 and 17 months,
respectively. As an example, figure 3 shows the patterns of all
11 isolates from patient A, which were obtained during the
period September 1997 through June 1998.
Some authors have argued that infection with M. abscessus
is uncommon in patients with CF and that the clinical impact
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Figure 3. Pulsed-field gel electrophoresis patterns for 11 Mycobac-
terium abscessus isolates from patient A. The chromosomal DNA was
digested with DraI. Lanes 1–11, isolates recovered during the period from
September 1997 through June 1998 (see also figure 1); lane 12, yeast
DNA standard.
of infection is minimal—both arguments for nonsegregation
policies [7, 13]. Other studies have found that M. chelonae
group are among the mycobacterial species most frequently
isolated from patients with CF and that M. chelonae group has
a higher prevalence among patients with CF than in the general
population [1, 6, 8]. Kilby et al. [8] observed that patients with
positive AFB smears from whom M. chelonae group was sub-
sequently isolated suffered from a worsening of lung disease.
In a necropsy study, active mycobacterial disease was demon-
strated in 2 patients infected with M. abscessus [12]. Moreover,
in a recent case report, the results of histological examination
indicated that invasive pulmonary disease with M. abscessus
was present in a patient with CF for several years [4].
In the present study, patient A was treated twice with ami-
kacin and rifabutin after AFB smears of respiratory specimens
were highly positive. M. abscessus was isolated, and disease
worsened significantly. After both courses of treatment, the
patient’s pulmonary function recovered promptly and the
mycobacterial burden in the sputum was greatly reduced. It is
noteworthy that patient A was not colonized or infected by
Pseudomonas at the time. Although the number of patients
treated in this study was too small to allow any analysis, the
course of disease in patient A suggests that M. abscessus was
producing the disease and responded to therapy. Nontuber-
culous mycobacteria other than M. abscessus were recovered
from patients in this study: M. avium-intracellulare, which
might also cause pulmonary disease in patients with CF [8],
and M. interjectum, M. simiae, and M. gordonae, which are
generally considered avirulent [10].
In the retrospective study presented here, nontuberculous
mycobacteria were recovered multiple times from 15 of 214
patients with CF; 5 of these 15 were colonized or infected with
M. abscessus. The study population was seen in a clinic. We
failed to detect evidence that M. abscessus colonization or in-
fection had originated from the same source or that person-
to-person transmission had occurred. We conclude that, in this
setting, there is no need to segregate patients with CF who are
colonized or infected with M. abscessus from those who are
not.
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